SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: John Metcalf who wrote (908)11/6/1997 4:30:00 PM
From: Steve Harmon  Read Replies (1) of 2742
 
Receiving another $3 mil. from Immunex this month. Immunex will pay up. Actually the $500,000 share buy back is actually less than 4% of CIST's cash and cash receivables from IMNX. Cash burn at CIST is extremely low.

I am just stating that this is just one way for CIST to eliminate the current over hang from MARK CAPITAL. The market makers in CIST's stock know of this selling pressure and until it is eliminated CIST will continue to trade at these SILLY levels.

Oh what the heck, just use $250,000 or less than 2% of CIST'S cash and cash receivables in a buyback. At these levels that would take care of the overhang and still give CIST good stock support.

Remember, MGT just dished out $150,000 in bonuses and salary increases recently to themselves(which i thought was well deserved). So money must not be that tight.

I just thought that the CIST shareholders could be rewarded also.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext